Trademark Overview
On Thursday, February 17, 2022, a trademark application was filed for RGC-COV19 with the United States Patent and Trademark Office. The USPTO has given the RGC-COV19 trademark a serial number of 97271558. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, July 13, 2023. This trademark is owned by REGENCELL BIOSCIENCE LIMITED. The RGC-COV19 trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals and medical preparations; sanitary preparations for medical purposes; pharmaceutical preparations for the treatment of diseases; pharmaceutical preparations for use in the diagnosis, prevention and treatment of COVID-19, coronavirus disease, and respiratory diseases and disorders; preparations for relief of symptoms of common colds, influenza and COVID-19; medical chemical preparations; medical diagnostic preparations; medical drugs; medicines for human purposes; medicinal capsules; therapeutic or medical nutritional preparations; medicinal tea; medicinal herbs; herbal medicines; dietary substances adapted for medical uses; tonics (medicines); Chinese traditional medicines; Chinese traditional medicines for the treatment of COVID-19, coronavirus disease and respiratory diseases; Chinese patent medicines for the treatment of disease; medicinal preparations for the treatment of diseases; biological health food supplements; nutraceutical preparations
